
    
      This is a Phase III, single-arm study performed in patients who completed the AOP2014 arm of
      the PROUD-PV study or are currently participating in the CONTINUATION-PV study. After signing
      the informed consent form (ICF), approximately 30 patients will be enrolled consecutively
      into the study at participating sites according to the inclusion and exclusion criteria.
    
  